Daily Target 2X Long MRNA ETF (MRNX) stock surged +10.25%, trading at $81.41 on AMEX, up from the previous close of $73.84. The stock opened at $74.73, fluctuating between $72.45 and $87.50 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 74.73 | 87.50 | 72.45 | 81.41 | 259.15K |
| Sep 10, 2026 | 71.71 | 74.25 | 67.19 | 73.84 | 146.66K |
| Sep 09, 2026 | 77.74 | 81.85 | 72.57 | 72.66 | 154.25K |
| Sep 08, 2026 | 84.22 | 86.09 | 77.36 | 78.06 | 222.94K |
| Sep 04, 2026 | 93.29 | 93.76 | 79.49 | 84.15 | 305.41K |
| Sep 03, 2026 | 84.99 | 88.62 | 81.02 | 88.29 | 0 |
| Sep 02, 2026 | 91.62 | 97.58 | 85.55 | 90.85 | 327.16K |
| Sep 01, 2026 | 78.37 | 95.47 | 76.77 | 95.11 | 546.77K |
| Aug 31, 2026 | 72.03 | 83.50 | 72.03 | 79.50 | 477.49K |
| Aug 28, 2026 | 76.00 | 77.54 | 71.39 | 76.89 | 427.08K |
| Aug 27, 2026 | 83.91 | 89.09 | 77.48 | 82.42 | 524.28K |
| Aug 26, 2026 | 97.29 | 99.20 | 85.16 | 90.77 | 465.35K |
| Aug 25, 2026 | 85.01 | 105.71 | 82.51 | 103.09 | 998.59K |
| Aug 24, 2026 | 84.92 | 87.30 | 69.50 | 79.95 | 706.03K |
| Aug 21, 2026 | 74.00 | 103.86 | 74.00 | 87.53 | 1.89M |
| Aug 20, 2026 | 101.93 | 106.82 | 67.04 | 74.31 | 1.9M |
| Aug 19, 2026 | 84.36 | 143.84 | 82.52 | 141.64 | 2.88M |
| Aug 18, 2026 | 31.37 | 32.06 | 30.50 | 31.33 | 13.41K |
| Aug 17, 2026 | 32.74 | 33.86 | 31.55 | 32.88 | 32.18K |
| Aug 14, 2026 | 30.35 | 32.00 | 30.05 | 31.65 | 66.46K |
The MRNX fund is designed to generate returns by taking a leveraged, bullish stance on the daily share price movements of Moderna, Inc. (MRNA). It achieves this primarily through the use of swap agreements and short-term listed call options. Its objective is to deliver a daily return equivalent to 200% (twice) the daily percentage change in MRNA's stock price, which it maintains through daily rebalancing. However, holding the fund for periods exceeding a single day may lead to actual returns that deviate significantly from this 2x daily target, influenced by factors like market volatility, compounding, and rebalancing impacts. For collateral supporting its derivative contracts, MRNX may also invest in stable assets such as U.S. government securities, money market funds, short-term bond exchange-traded funds (ETFs), and investment-grade corporate debt.
| Employees | 0 |
| Beta | -1.97 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Financial Services |
| Industry | Asset Management - Leveraged |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep